229 results on '"Tenembaum, Silvia"'
Search Results
2. A Clinical Neurological Approach to the Child With Adenosine Deaminase Deficiency
3. Neuromyelitis Optica spectrum disorders in Argentina: A hospital-based study
4. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
5. Performance of the 2023 Adult Criteria for the Radiologically Isolated Syndrome in Children and Comparison to the 2009 Criteria (P4-6.007)
6. Diagnosis and classification of optic neuritis
7. Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG
8. Restoring immune tolerance in neuromyelitis optica
9. Restoring immune tolerance in neuromyelitis optica
10. International MOGAD criteria
11. Population Pharmacodynamic Modelling of the CD19+ Suppression Effects of Rituximab in Paediatric Patients with Neurological and Autoimmune Diseases
12. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
13. Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.
14. International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis
15. International Pediatric MS Study Group Clinical Trials Summit
16. Pediatric Multiple Sclerosis: Distinguishing Clinical and MR Imaging Features
17. Prognostic indicators of improvement with therapeutic plasma exchange in pediatric demyelination
18. Treatment of neuromyelitis optica: Review and recommendations
19. Intensive Safety Monitoring of Rituximab (Biosimilar Novex® and the Innovator) in Pediatric Patients With Complex Diseases
20. Treatment of Acute Disseminated Encephalomyelitis
21. Pediatric demyelinating disease and anti‐MOG antibody
22. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein
23. Acute disseminated encephalomyelitis
24. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study
25. Intensive Safety Monitoring of Rituximab (Biosimilar Novex® and the Innovator) in Pediatric Patients With Complex Diseases.
26. Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
27. Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations
28. Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations.
29. Prothrombotic Disorders in Children With Moyamoya Syndrome
30. Interferon-β1a–induced juvenile chronic arthritis in a genetically predisposed young patient with multiple sclerosis: comment on the case report by Levesque et al
31. Atypical Evolutions of Benign Localization-Related Epilepsies in Children: Are They Predictable?
32. Position Statement:Emerging genetic therapies for rare disorders
33. Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis
34. Treatment of MOG-IgG-associated demyelination with Rituximab: a multinational study of 98 patients (S13.003)
35. Pediatric Multiple Sclerosis
36. Neuromyelitis optica spectrum disorders in children and adolescents
37. International Pediatric MS Study Group Global Members Symposium report: Table
38. Acute disseminated encephalomyelitis
39. Pediatric multiple sclerosis
40. Dystonia in a Patient with Autosomal‐Dominant Progressive External Ophthalmoplegia Type 1 Caused by Mutation in the POLG Gene
41. Subcutaneous interferon β-1a in pediatric patients with multiple sclerosis: Regional differences in clinical features, disease management, and treatment outcomes in an international retrospective study
42. Comment on multiphasic disseminated encephalomyelitis followed by optic neuritis in a child with gluten sensitivity
43. Characterization of the Spectrum of Argentinean Neuromyelitis Optica according to the diagnostic criteria and AQP4 IgG serostatus (P5.276)
44. Catastrophic Encephalopathy as Presenting Picture of Susac's Syndrome in two Children (P6.268)
45. Spectrum of MOG Autoantibody-Associated Inflammatory Diseases in Pediatric Patients (P5.275)
46. Spectrum of MOG Autoantibody-Associated Inflammatory Diseases in Pediatric Patients (I4-3A)
47. Dystonia in a Patient with Autosomal-Dominant Progressive External Ophthalmoplegia Type 1 Caused by Mutation in the POLG Gene.
48. OTRAS EPILEPSIAS INMUNOMEDIADAS
49. Revised Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders (S63.001)
50. Treatment of multiple sclerosis and neuromyelitis optica in children and adolescents
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.